Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04341389 |
|---|---|
| Brief Title: | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) (CTII-nCoV) |
| First Submitted : | April 7, 2020 |
| First Submitted that Met QC Criteria : | April 9, 2020 |
| First Posted : | April 10, 2020 |
| Last Update Submitted that Met QC Criteria : | May 22, 2023 |
| Last Update Posted : | May 24, 2023 |